Straumann Holding AG

PINK:SAUHF USA Medical Instruments & Supplies
Market Cap
$16.82 Billion
Market Cap Rank
#1527 Global
#1147 in USA
Share Price
$105.48
Change (1 day)
-5.52%
52-Week Range
$105.48 - $131.86
All Time High
$213.65
About

Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company also offers dental implants and components made f… Read more

Straumann Holding AG (SAUHF) - Net Assets

Latest net assets as of June 2025: $2.06 Billion USD

Based on the latest financial reports, Straumann Holding AG (SAUHF) has net assets worth $2.06 Billion USD as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($3.51 Billion) and total liabilities ($1.45 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $2.06 Billion
% of Total Assets 58.69%
Annual Growth Rate 11.4%
5-Year Change 68.92%
10-Year Change 237.83%
Growth Volatility 18.98

Straumann Holding AG - Net Assets Trend (2002–2024)

This chart illustrates how Straumann Holding AG's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Straumann Holding AG (2002–2024)

The table below shows the annual net assets of Straumann Holding AG from 2002 to 2024.

Year Net Assets Change
2024-12-31 $2.04 Billion +11.16%
2023-12-31 $1.84 Billion -0.82%
2022-12-31 $1.85 Billion +23.55%
2021-12-31 $1.50 Billion +24.01%
2020-12-31 $1.21 Billion -11.50%
2019-12-31 $1.37 Billion +13.53%
2018-12-31 $1.20 Billion +12.56%
2017-12-31 $1.07 Billion +68.84%
2016-12-31 $633.68 Million +4.75%
2015-12-31 $604.97 Million -17.90%
2014-12-31 $736.84 Million +16.70%
2013-12-31 $631.38 Million +0.03%
2012-12-31 $631.21 Million -5.95%
2011-12-31 $671.12 Million -3.52%
2010-12-31 $695.63 Million +9.48%
2009-12-31 $635.42 Million +18.18%
2008-12-31 $537.66 Million -13.77%
2007-12-31 $623.50 Million +23.81%
2006-12-31 $503.57 Million +19.90%
2005-12-31 $419.99 Million +34.77%
2004-12-31 $311.63 Million +21.75%
2003-12-31 $255.97 Million +34.73%
2002-12-31 $189.98 Million --

Equity Component Analysis

This analysis shows how different components contribute to Straumann Holding AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 1194.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings $2.04 Billion 99.92%
Common Stock $1.59 Million 0.08%
Total Equity $2.04 Billion 100.00%

Straumann Holding AG Competitors by Market Cap

The table below lists competitors of Straumann Holding AG ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Straumann Holding AG's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 1,836,179,000 to 2,040,131,000, a change of 203,952,000 (11.1%).
  • Net income of 388,316,000 contributed positively to equity growth.
  • Dividend payments of 135,428,000 reduced retained earnings.
  • Share repurchases of 27,823,000 reduced equity.
  • New share issuances of 10,240,000 increased equity.
  • Other comprehensive income increased equity by 578,878,999.
  • Other factors decreased equity by 610,231,999.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $388.32 Million +19.03%
Dividends Paid $135.43 Million -6.64%
Share Repurchases $27.82 Million -1.36%
Share Issuances $10.24 Million +0.5%
Other Comprehensive Income $578.88 Million +28.37%
Other Changes $-610.23 Million -29.91%
Total Change $- 11.11%

Book Value vs Market Value Analysis

This analysis compares Straumann Holding AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 8.25x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 86.45x to 8.25x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2002-12-31 $1.22 $105.48 x
2003-12-31 $1.64 $105.48 x
2004-12-31 $1.99 $105.48 x
2005-12-31 $2.68 $105.48 x
2006-12-31 $3.22 $105.48 x
2007-12-31 $3.98 $105.48 x
2008-12-31 $3.45 $105.48 x
2009-12-31 $4.07 $105.48 x
2010-12-31 $4.44 $105.48 x
2011-12-31 $4.30 $105.48 x
2012-12-31 $4.08 $105.48 x
2013-12-31 $4.06 $105.48 x
2014-12-31 $4.68 $105.48 x
2015-12-31 $3.82 $105.48 x
2016-12-31 $4.03 $105.48 x
2017-12-31 $6.87 $105.48 x
2018-12-31 $7.56 $105.48 x
2019-12-31 $8.57 $105.48 x
2020-12-31 $7.57 $105.48 x
2021-12-31 $9.37 $105.48 x
2022-12-31 $11.60 $105.48 x
2023-12-31 $11.50 $105.48 x
2024-12-31 $12.79 $105.48 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Straumann Holding AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 19.03%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 15.51%
  • • Asset Turnover: 0.69x
  • • Equity Multiplier: 1.77x
  • Recent ROE (19.03%) is below the historical average (21.15%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2002 29.63% 20.36% 1.10x 1.33x $37.08 Million
2003 31.60% 23.35% 0.98x 1.38x $54.89 Million
2004 32.29% 23.78% 1.04x 1.31x $69.00 Million
2005 30.55% 25.09% 0.95x 1.28x $86.02 Million
2006 28.14% 23.65% 0.93x 1.28x $91.37 Million
2007 28.38% 24.64% 0.75x 1.53x $113.90 Million
2008 1.52% 1.05% 1.07x 1.35x $-45.60 Million
2009 23.04% 19.88% 0.92x 1.26x $82.83 Million
2010 18.84% 17.77% 0.86x 1.23x $61.52 Million
2011 10.57% 10.23% 0.85x 1.21x $3.84 Million
2012 5.77% 5.31% 0.89x 1.22x $-26.68 Million
2013 16.03% 14.88% 0.67x 1.62x $38.06 Million
2014 21.42% 22.22% 0.61x 1.58x $84.14 Million
2015 11.68% 8.85% 0.76x 1.73x $10.18 Million
2016 36.23% 25.02% 0.84x 1.72x $166.23 Million
2017 25.50% 24.54% 0.66x 1.57x $165.91 Million
2018 22.71% 20.00% 0.73x 1.55x $152.68 Million
2019 22.48% 19.20% 0.67x 1.75x $170.13 Million
2020 7.58% 6.40% 0.56x 2.12x $-29.19 Million
2021 26.49% 19.59% 0.68x 1.98x $246.54 Million
2022 23.48% 18.73% 0.69x 1.82x $249.63 Million
2023 13.40% 10.20% 0.73x 1.81x $62.45 Million
2024 19.03% 15.51% 0.69x 1.77x $184.30 Million

Industry Comparison

This section compares Straumann Holding AG's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

  • Industry: Medical Instruments & Supplies
  • Average net assets among peers: $2,683,526,542
  • Average return on equity (ROE) among peers: -32.48%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Straumann Holding AG (SAUHF) $2.06 Billion 29.63% 0.70x $11.38 Billion
ANGELALIGN TECHNOLOGY INC (AGLFF) $480.24 Million 2.52% 0.41x $405.57 Million
Akoya Biosciences Inc (AKYA) $-30.16 Million 0.00% 0.00x $16.24 Million
Alcon AG (ALC) $19.68 Billion 1.70% 0.48x $37.82 Billion
Align Technology Inc (ALGN) $3.85 Billion 10.94% 0.61x $11.75 Billion
AngioDynamics Inc (ANGO) $355.71 Million 3.06% 0.15x $354.40 Million
Ansell Limited (ANSLF) $386.33 Million -0.45% 0.87x $2.58 Billion
AptarGroup Inc (ATR) $2.07 Billion 11.57% 1.03x $8.27 Billion
AtriCure Inc (ATRC) $72.60 Million -15.79% 0.54x $1.42 Billion
Avinger Inc (AVGR) $-35.69 Million 0.00% 0.00x $1.26 Million
Anteris Technologies Global Corp. Common Stock (AVR) $9.03 Million -338.35% 0.77x $156.14 Million